Morey & Quinn Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$723K Sell
603
-29
-5% -$29.6K 0.47% 55
2026
Q1
$581K Sell
632
-29
-4% -$29.4K 0.41% 59
2025
Q4
$710K Buy
661
+10
+2% +$9.56K 0.51% 52
2025
Q3
$497K Buy
651
+28
+4% +$20.8K 0.37% 70
2025
Q2
$486K Buy
623
+102
+20% +$79.3K 0.39% 63
2025
Q1
$430K Buy
521
+3
+0.6% +$2.5K 0.36% 70
2024
Q4
$400K Buy
+518
New +$429K 0.34% 74

Other funds holding LLY

Morey & Quinn Wealth Partners's LLY Position: Q2 2026 in Review

Morey & Quinn Wealth Partners reduced its Eli Lilly (LLY) stake by 4.6% in Q2 2026, selling an estimated $29.6K and leaving 603 shares worth $723K. The position accounts for 0.47% of the portfolio, ranked #55.

Morey & Quinn Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,713 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Morey & Quinn Wealth Partners held 603 shares of Eli Lilly worth $723K as of Q2 2026.
  • Morey & Quinn Wealth Partners sold 29 Eli Lilly shares in Q2 2026, an estimated $29.6K.
  • Eli Lilly made up 0.47% of Morey & Quinn Wealth Partners's portfolio in Q2 2026, its #55 holding.
  • Morey & Quinn Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,713 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Morey & Quinn Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.